Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine

D Dodick; RB Lipton; V Martin; V Papademetriou; W Rosamond; Antoinette Maassen van den Brink; H Loutfi; M Welch; PJ Goadsby; S Hahn; S Hutchinson; D Matchar; S Silberstein; TR Smith; A Purdy; J Saiers

doi:10.1111/j.1526-4610.2004.04078.x

Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine

D Dodick, RB Lipton, V Martin, V Papademetriou, W Rosamond, Antoinette Maassen van den Brink, H Loutfi, M Welch, PJ Goadsby, S Hahn, S Hutchinson, D Matchar, S Silberstein, TR Smith, A Purdy, J Saiers

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

320 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	414-425
Number of pages	12
Journal	Headache
Volume	44
DOIs	https://doi.org/10.1111/j.1526-4610.2004.04078.x
Publication status	Published - 2004

Research programs

EMC COEUR-01-43-01

Access to Document

10.1111/j.1526-4610.2004.04078.x

http://hdl.handle.net/1765/73924

Cite this

Dodick, D., Lipton, RB., Martin, V., Papademetriou, V., Rosamond, W., Maassen van den Brink, A., Loutfi, H., Welch, M., Goadsby, PJ., Hahn, S., Hutchinson, S., Matchar, D., Silberstein, S., Smith, TR., Purdy, A., & Saiers, J. (2004). Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache, 44, 414-425. https://doi.org/10.1111/j.1526-4610.2004.04078.x

@article{ade17b9b80dc4a52a05e60c01c089f15,

title = "Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine",

author = "D Dodick and RB Lipton and V Martin and V Papademetriou and W Rosamond and {Maassen van den Brink}, Antoinette and H Loutfi and M Welch and PJ Goadsby and S Hahn and S Hutchinson and D Matchar and S Silberstein and TR Smith and A Purdy and J Saiers",

year = "2004",

doi = "10.1111/j.1526-4610.2004.04078.x",

language = "Undefined/Unknown",

volume = "44",

pages = "414--425",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Dodick, D, Lipton, RB, Martin, V, Papademetriou, V, Rosamond, W, Maassen van den Brink, A, Loutfi, H, Welch, M, Goadsby, PJ, Hahn, S, Hutchinson, S, Matchar, D, Silberstein, S, Smith, TR, Purdy, A & Saiers, J 2004, 'Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine', Headache, vol. 44, pp. 414-425. https://doi.org/10.1111/j.1526-4610.2004.04078.x

TY - JOUR

T1 - Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine

AU - Dodick, D

AU - Lipton, RB

AU - Martin, V

AU - Papademetriou, V

AU - Rosamond, W

AU - Maassen van den Brink, Antoinette

AU - Loutfi, H

AU - Welch, M

AU - Goadsby, PJ

AU - Hahn, S

AU - Hutchinson, S

AU - Matchar, D

AU - Silberstein, S

AU - Smith, TR

AU - Purdy, A

AU - Saiers, J

PY - 2004

Y1 - 2004

U2 - 10.1111/j.1526-4610.2004.04078.x

DO - 10.1111/j.1526-4610.2004.04078.x

M3 - Article

SN - 0017-8748

VL - 44

SP - 414

EP - 425

JO - Headache

JF - Headache

ER -